Recombinant ArtinM activates mast cells.
Valéria Cintra Barbosa-LorenziNerry Tatiana CecilioPatricia Andressa de Almeida BuranelloMaria Cristina PrancheviciusMaria Helena S GoldmanGabriela Pereira-da-SilvaMaria Cristina Roque-BarreiraMaria Célia JamurConstance OliverPublished in: BMC immunology (2016)
The lectin rArtinM has the ability to activate and degranulate mast cells via their CRDs. The present study indicates that rArtinM is a suitable substitute for the native form, jArtinM, and that rArtinM may serve as an important and reliable pharmacological agent.
Keyphrases